Accelerating scientific discovery with Co-Scientist
Summary
Co-Scientist is a multi-agent AI system, built on Gemini, designed to accelerate scientific discovery by augmenting hypothesis generation. This system helps scientists formulate demonstrably novel research hypotheses for experimental verification, conditioned on research objectives and prior evidence. Its architecture features a multi-agent design with an asynchronous task execution framework, enabling flexible compute scaling, and incorporates a tournament evolution process for self-improving hypothesis generation. Automated evaluations confirm that scaling test-time compute continuously improves hypothesis quality. While general-purpose, Co-Scientist was validated in three biomedical applications: drug repurposing, novel target discovery, and explaining anti-microbial resistance. Notably, it identified new drug repurposing candidates and synergistic combination therapies for acute myeloid leukemia, which were subsequently validated through in vitro experiments. This work was published on May 19, 2026.
Key takeaway
For research scientists exploring complex problems, Co-Scientist offers a powerful AI-driven approach to accelerate discovery. You should consider integrating multi-agent AI systems like Co-Scientist into your workflow to generate and validate novel hypotheses more efficiently. This system's ability to identify new drug candidates and synergistic therapies, validated in vitro, suggests a significant shift in how you might approach early-stage research and experimental design.
Key insights
Co-Scientist, a Gemini-based multi-agent AI, accelerates scientific discovery by generating and refining novel, verifiable hypotheses.
Principles
- Multi-agent AI enhances hypothesis generation.
- Asynchronous task execution scales compute.
- Tournament evolution improves hypothesis quality.
Method
Co-Scientist agents continuously generate, critique, and refine hypotheses, leveraging asynchronous task execution and a tournament evolution process, accelerated by scaling test-time compute.
In practice
- Identify drug repurposing candidates.
- Discover novel therapeutic targets.
- Explain anti-microbial resistance mechanisms.
Topics
- Multi-agent AI
- Gemini
- Hypothesis Generation
- Drug Repurposing
- Biomedical Research
- Scientific Discovery
Best for: AI Scientist, Research Scientist
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.